Nanotechnology

Nanobiosym Awarded $2M Contract From U.S. Defense Threat Reduction Agency (DTRA)

Published in Health Business Week, October 12th, 2007

Nanobiosym Inc., announced that it has been awarded a highly competitive $2 million contract from the United States Defense Threat Reduction Agency (DTRA), a branch of the US Department of Defense. The winners of this award were selected after an intense competition among many of the nation's leading US academic, government, and industrial labs.

Nanobiosym, and its commercial partner Nanobiosym Diagnostics, have been privately developing Gene-RADAR(R), a portable nanotechnology-enabled platform, that can rapidly and accurately detect genetic fingerprints from any biological organism. The company's vision is to give patients worldwide real-time access to their own...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Business Week

Source: Health Business Week (2007-10-12)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry